PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNo difference in viability found between mosaic and non-mosaic embryos

BioNews

No difference in viability found between mosaic and non-mosaic embryos

Published 19 November 2021 posted in News and appears in BioNews 1122

Author

Tsvetana Stoilova

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Many IVF embryos discarded due to chromosomal abnormalities could lead to viable pregnancies and healthy babies, a new non-selection clinical trial has suggested...

Many IVF embryos discarded due to chromosomal abnormalities could lead to viable pregnancies and healthy babies, a new non-selection clinical trial has suggested.

Currently fewer than three percent of mosaic embryos, which have a mixture of normal and aneuploid cells, are transferred into the uterus during IVF due to a belief they are not viable. This practice limits IVF where few alternative embryos are available to a patient, although there is limited evidence to suggest that mosaic embryos are not viable as a few abnormal cells might not affect fetal development.

'It was already known that putative mosaic embryos can develop to term and make healthy babies, but many of the previous studies that looked at this issue were affected by selection bias toward a population of patients that had a poor prognosis because they had previously failed implantations with euploid embryos,' said first author of the study Dr Antonio Capalbo, laboratory director at Igenomix, Marostica, Italy, which specialises in genomic testing services.

In the clinical trial, published in the journal American Journal of Human Genetics, embryos were tested with pre-implantation genetic testing that looked specifically for mosaic aneuploidy. In addition to euploid embryos (those with no aneuploidy), embryos with low-grade mosaicism (20 to 30 percent aneuploid cells) and medium-grade mosaicism (30 to 50 percent aneuploid cells) were blindly reported as euploid and implanted. This strategy avoided bias as any embryo that fitted the defined criteria could be used for implantation.

The investigators found that across 484 euploid, 282 low-grade mosaic, and 131 medium-grade mosaic embryos, the mosaic embryos were as likely to implant in the uterus as the normal embryos, and had the same likelihood of becoming a healthy baby carried to term. The obstetric and neonatal outcomes were also similar across the three groups.

Miscarriage rates were similar across the three groups and of the pregnancies which resulted in miscarriage which were investigated, none were due to aneuploidy.

'This is an area that has created a lot of controversy over the last decade, with some who believe it blindly and some who believe it's wrong. It has divided the field' Dr Ippokratis Sarris, director of King's Fertility, who was not involved in the study, commented in the Telegraph. 'Clinicians and doctors are asking: "what should I do with mosaic embryos?" We're becoming more confident in putting back mosaic embryos and seeing what happens.'

The researchers expect the study to change current guidelines on the use and reporting of mosaic embryos prior to IVF treatment, thus allowing patients to make more informed decisions about the transfer of mosaic embryos, which can be deemed healthy and normal according to the trial.

Sources and References

  • 18/11/2021
    American Society of Human Genetics
    Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial
  • 18/11/2021
    EurekAlert
    Many IVF embryos not implanted due to mosaic abnormalities may be viable
  • 06/11/2021
    The Telegraph
    IVF would be more successful if clinics also used ‘abnormal’ embryos, research shows

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
14 January 2022 • 2 minutes read

Adverse outcomes associated with assisted reproduction not caused by IVF

by Tsvetana Stoilova

Fertility treatment is not the cause of adverse birth outcomes in babies born after medically assisted reproduction...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
6 December 2021 • 4 minutes read

PGT-A in young, good prognosis populations

by Dr Eric J Forman

A recent large randomised trial published in the New England Journal of Medicine is receiving significant attention with clinicians who are critical of preimplantation genetic testing for aneuploidy (PGT-A) claiming it provides evidence that PGT-A does not improve IVF outcomes and should not be used outside of research settings…

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
26 November 2021 • 2 minutes read

PGT-A did not improve live birth rate in clinic trial

by Ruth Retassie

A recent study found that preimplantation genetic testing for aneuploidy may not improve live birth rate...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
5 November 2021 • 2 minutes read

Embryonic stem cells can self-destruct when defective

by Beatrice Costa

Insight into genetic control of human embryonic stem cells' fate has offered new insight into cancer genetics and could inform future work in regenerative medicine...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
26 July 2021 • 4 minutes read

IVF add-ons: are they supported by evidence?

by Sarah Lensen

IVF add-ons are procedures, techniques or medicines which can be used in addition to standard IVF protocols. They are usually offered by IVF clinics, and used by patients, with the hope that they will improve the chance of IVF success...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 May 2021 • 2 minutes read

Embryos often develop into healthy babies despite aneuploid genetic tests

by Dr Katie Howe

Some of the faulty embryos currently ruled out for use in IVF can self-correct and lead to healthy pregnancies, research has revealed..

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
17 July 2020 • 2 minutes read

Embryos with abnormal cells may be common and result in IVF success

by Emma Lamb

Errors in the genetic material of embryonic cells following IVF are more common and less damaging in normal human development than previously thought...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Switzerland's marriage equality law widens access to IVF

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856